As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 ...

Serena Williams opens up about her weight loss struggles and the use of GLP-1 medications, highlighting issues of access and ...

The announcement quickly drew attention from actress and activist Jameela Jamil, who took to Instagram to caution fans about ...

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...

Even when elite athletes and celebrities are seemingly transparent about their health and bodies, we still may not be getting ...

When the FDA took Novo Nordisk and Eli Lilly’s GLP-1 medications off of the drug shortage list, the move should have been a ...

Amongst the horde of huge-name stars who've admitted to taking these types of medication in a bid to help shed a few pounds ...

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially ...

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...